Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.

Colombel JF, Reinisch W, Mantzaris GJ, Kornbluth A, Rutgeerts P, Tang KL, Oortwijn A, Bevelander GS, Cornillie FJ, Sandborn WJ.

Aliment Pharmacol Ther. 2015 Apr;41(8):734-46. doi: 10.1111/apt.13139. Epub 2015 Mar 1.

PMID:
25728587
2.

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease.

Ha C, Mathur J, Kornbluth A.

Expert Rev Gastroenterol Hepatol. 2015 Apr;9(4):497-505. doi: 10.1586/17474124.2015.983079. Epub 2015 Jan 20.

PMID:
25600263
3.

Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC.

Bouguen G, Sninsky C, Tang KL, Colombel JF, DʼHaens G, Kornbluth A, Mantzaris GJ, Rachmilewitz D, Reinisch W, Rutgeerts P, Molenda M, Jannekevan der Woude C, Sandborn WJ.

Inflamm Bowel Dis. 2015 Mar;21(3):606-14. doi: 10.1097/MIB.0000000000000302.

PMID:
25581826
4.

Factors associated with short- and long-term outcomes of therapy for Crohn's disease.

Reinisch W, Colombel JF, Sandborn WJ, Mantzaris GJ, Kornbluth A, Adedokun OJ, Miller M, Tang KL, Rutgeerts P, Cornillie F.

Clin Gastroenterol Hepatol. 2015 Mar;13(3):539-547.e2. doi: 10.1016/j.cgh.2014.09.031. Epub 2014 Sep 19.

5.

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.

Peyrin-Biroulet L, Reinisch W, Colombel JF, Mantzaris GJ, Kornbluth A, Diamond R, Rutgeerts P, Tang LK, Cornillie FJ, Sandborn WJ.

Gut. 2014 Jan;63(1):88-95. doi: 10.1136/gutjnl-2013-304984. Epub 2013 Aug 23.

PMID:
23974954
6.

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens GR, van der Woude CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts PJ; International Organization for the Study of Inflammatory Bowel Diseases.

Gastroenterology. 2013 Nov;145(5):978-986.e5. doi: 10.1053/j.gastro.2013.08.010. Epub 2013 Aug 14.

PMID:
23954314
7.

Adalimumab: Another Treatment Option for Moderate-to-Severe UC.

Kornbluth AA.

Gastroenterol Hepatol (N Y). 2013 May;9(5):321. No abstract available.

8.

Clinical presentation and outcomes of inflammatory bowel disease patients admitted to the intensive care unit.

Ha C, Maser EA, Kornbluth A.

J Clin Gastroenterol. 2013 Jul;47(6):485-90. doi: 10.1097/MCG.0b013e318275d981.

PMID:
23388843
9.

The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis.

Lazarev M, Present DH, Lichtiger S, Kornbluth A, Marion J, Chapman M, Ullman TA.

J Clin Gastroenterol. 2012 Oct;46(9):764-7. doi: 10.1097/MCG.0b013e31824e14a8.

PMID:
22751334
10.

Double balloon enteroscopy in Crohn's disease: background and current state of play.

Murphy SJ, Kornbluth A.

Curr Drug Targets. 2012 Sep 1;13(10):1280-6. Review.

PMID:
22702633
11.

The MMAS-8, a screening tool for determining nonadherent behavior, should not be dismissed in IBD.

Trindade AJ, Tinsley A, Kornbluth A, Ullman TA.

Am J Gastroenterol. 2012 Jun;107(6):951-2; author reply 952. doi: 10.1038/ajg.2012.73. No abstract available.

PMID:
22664851
12.

Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population.

Ha C, Ullman TA, Siegel CA, Kornbluth A.

Clin Gastroenterol Hepatol. 2012 Sep;10(9):1002-7; quiz e78. doi: 10.1016/j.cgh.2012.02.004. Epub 2012 Feb 15.

PMID:
22343692
13.

Cyclosporine versus infliximab for the treatment of severe ulcerative colitis.

Kornbluth A.

Gastroenterol Hepatol (N Y). 2011 Oct;7(10):677-9. No abstract available.

14.

Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management.

Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen LE, Gostout C, Lopez-Nava G, Shikora S, Brooks J.

Obes Surg. 2011 Oct;21(10):1499-507. doi: 10.1007/s11695-011-0424-z.

15.

Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study.

Peter I, Mitchell AA, Ozelius L, Erazo M, Hu J, Doheny D, Abreu MT, Present DH, Ullman T, Benkov K, Korelitz BI, Mayer L, Desnick RJ; New York Crohn's Disease Working Group.

BMC Med Genet. 2011 May 6;12:63. doi: 10.1186/1471-2350-12-63.

16.

Use of video capsule endoscopy in Crohn's disease.

Swaminath A, Kornbluth A.

Minerva Gastroenterol Dietol. 2010 Dec;56(4):437-49. Review.

PMID:
21139542
17.

Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.

Hanauer SB, Kornbluth AA, Messick J, Rubin DT, Sandborn WJ, Sands BE.

Inflamm Bowel Dis. 2010 Dec;16 Suppl 1:S1-11. doi: 10.1002/ibd.21529. Review. No abstract available.

PMID:
21104734
18.

Mucosal healing in inflammatory bowel disease: where do we stand?

Ha C, Kornbluth A.

Curr Gastroenterol Rep. 2010 Dec;12(6):471-8. doi: 10.1007/s11894-010-0146-8. Review.

PMID:
20886319
19.

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence.

Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA.

Inflamm Bowel Dis. 2011 Feb;17(2):599-604. doi: 10.1002/ibd.21310.

PMID:
20848512
20.

Double balloon enteroscopy in Crohn's disease: where are we now and where should we go?

Murphy SJ, Kornbluth A.

Inflamm Bowel Dis. 2011 Jan;17(1):485-90. doi: 10.1002/ibd.21373. Review.

PMID:
20577975
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk